Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus: Lessons Learned and Future Directions

Abhinav Sharma, Neha J. Pagidipati, Robert M. Califf, Darren K. McGuire, Jennifer B. Green, Dave Demets, Jyothis Thomas George, Hertzel C. Gerstein, Todd Hobbs, Rury R. Holman, Francesca C. Lawson, Lawrence A. Leiter, Marc A. Pfeffer, Jane Reusch, Jeffrey S. Riesmeyer, Matthew T. Roe, Yves Rosenberg, Robert Temple, Stephen Wiviott, John McMurrayChristopher Granger

Research output: Contribution to journalReview articlepeer-review

22 Scopus citations

Fingerprint

Dive into the research topics of 'Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus: Lessons Learned and Future Directions'. Together they form a unique fingerprint.

Medicine & Life Sciences